These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 36600852)

  • 1. SARS-CoV-2 Omicron Variant in Patients With Chronic Lymphocytic Leukemia: Case Series.
    Khamees I; Ali EA; Malkawi L; Rozi W; Yassin MA
    Cureus; 2022 Nov; 14(11):e32041. PubMed ID: 36600852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2 Omicron Variant in Patients With Chronic Myeloid Leukemia: A Retrospective Study.
    Ali EA; Khamees I; Abu-Tineh M; Qasim H; Alshurafa A; Ahmed K; Malkawi L; Yassin MA
    Cureus; 2022 Apr; 14(4):e23863. PubMed ID: 35411288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Case Series of SARS-CoV-2 Omicron Variant in Patients With Acute Leukemia.
    Ali EA; Alamin MA; Abu-Tineh M; Ahmed K; Alshurafa A; Rozi W; Yassin MA
    Cureus; 2022 May; 14(5):e25196. PubMed ID: 35747002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with CLL have a lower risk of death from COVID-19 in the Omicron era.
    Niemann CU; da Cunha-Bang C; Helleberg M; Ostrowski SR; Brieghel C
    Blood; 2022 Aug; 140(5):445-450. PubMed ID: 35588468
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Patients with Philadelphia-Negative Myeloproliferative Neoplasm: A Single Center Experience.
    Ali EAH; Khamees I; Alshurafa A; Qasim H; Abu-Tineh MA; Ahmed K; Saad E; Yassin M
    Oncology; 2022; 100(8):460-466. PubMed ID: 35882185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 Omicron Mutation Is Faster than the Chase: Multiple Mutations on Spike/ACE2 Interaction Residues.
    Kim S; Nguyen TT; Taitt AS; Jhun H; Park HY; Kim SH; Kim YG; Song EY; Lee Y; Yum H; Shin KC; Choi YK; Song CS; Yeom SC; Kim B; Netea M; Kim S
    Immune Netw; 2021 Dec; 21(6):e38. PubMed ID: 35036025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Glycosylated RBD Protein Induces Enhanced Neutralizing Antibodies against Omicron and Other Variants with Improved Protection against SARS-CoV-2 Infection.
    Shi J; Zheng J; Tai W; Verma AK; Zhang X; Geng Q; Wang G; Guan X; Malisheni MM; Odle AE; Zhang W; Li F; Perlman S; Du L
    J Virol; 2022 Sep; 96(17):e0011822. PubMed ID: 35972290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of SARS-CoV-2 Omicron variant and strategies for tackling the infection.
    Wu Y; Long Y; Wang F; Liu W; Wang Y
    Immun Inflamm Dis; 2022 Dec; 10(12):e733. PubMed ID: 36444634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Characteristics of Omicron SARS-CoV-2 Variant Infection After Non-mRNA-Based Vaccination in China.
    Zeng QL; Lv YJ; Liu XJ; Jiang ZY; Huang S; Li WZ; Yu ZJ
    Front Microbiol; 2022; 13():901826. PubMed ID: 35847120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 Omicron variant (B.1.1.529): A concern with immune escape.
    Sanyaolu A; Marinkovic A; Prakash S; Haider N; Williams M; Okorie C; Badaru O; Smith S
    World J Virol; 2022 May; 11(3):137-143. PubMed ID: 35665238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiological characteristics of 17 imported patients infected with SARS-CoV-2 Omicron variant.
    Liu X; Chen M; Zhou Z; Chen D; Mo J; Liu J
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 47(3):344-351. PubMed ID: 35545327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Omicron Variant of SARS-CoV-2 and Its Potential Impact on Dental Practice].
    Ren B; Liao BY; Wang JN; Peng X; Zhou XD
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2022 Mar; 53(2):175-180. PubMed ID: 35332714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in the Omicron variant development.
    Vitiello A; Ferrara F; Auti AM; Di Domenico M; Boccellino M
    J Intern Med; 2022 Jul; 292(1):81-90. PubMed ID: 35289434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical features of 19 children infected with the Omicron variant of severe acute respiratory syndrome coronavirus 2 in Hangzhou, China].
    Qi ZH; Bei ZF; Teng S; Wang HP; Li W; Zhao SY; Liu SR
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Oct; 24(10):1092-1097. PubMed ID: 36305108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SARS-CoV-2 Omicron variant: recent progress and future perspectives.
    Fan Y; Li X; Zhang L; Wan S; Zhang L; Zhou F
    Signal Transduct Target Ther; 2022 Apr; 7(1):141. PubMed ID: 35484110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An evolutionary insight into Severe Acute Respiratory Syndrome Coronavirus 2 Omicron variant of concern.
    Paz M; Aldunate F; Arce R; Ferreiro I; Cristina J
    Virus Res; 2022 Jun; 314():198753. PubMed ID: 35331836
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the SARS CoV-2 Omicron Variant Deadlier and More Transmissible Than Delta Variant?
    Duong BV; Larpruenrudee P; Fang T; Hossain SI; Saha SC; Gu Y; Islam MS
    Int J Environ Res Public Health; 2022 Apr; 19(8):. PubMed ID: 35457468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coronavirus disease 2019 (COVID-19)-related smell and taste impairment with widespread diffusion of severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) Omicron variant.
    Boscolo-Rizzo P; Tirelli G; Meloni P; Hopkins C; Madeddu G; De Vito A; Gardenal N; Valentinotti R; Tofanelli M; Borsetto D; Lechien JR; Polesel J; De Riu G; Vaira LA
    Int Forum Allergy Rhinol; 2022 Oct; 12(10):1273-1281. PubMed ID: 35286777
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facing the Omicron variant-how well do vaccines protect against mild and severe COVID-19? Third interim analysis of a living systematic review.
    Külper-Schiek W; Piechotta V; Pilic A; Batke M; Dreveton LS; Geurts B; Koch J; Köppe S; Treskova M; Vygen-Bonnet S; Waize M; Wichmann O; Harder T
    Front Immunol; 2022; 13():940562. PubMed ID: 36091023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omicron SARS-CoV-2 new variant: global prevalence and biological and clinical characteristics.
    Meo SA; Meo AS; Al-Jassir FF; Klonoff DC
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(24):8012-8018. PubMed ID: 34982465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.